|
Marker Gene Technologies, Inc
MGT is a primary manufacturer. Order from the
source! Kits for Marker Genes Detection, Fluorescent Reagents, Labelling
Reagents & Cell Regulatory Substrates.
Removal
of Marker Genes.
Marker
genes find numerous applications in animal and plant systems, but can also cause
consumer concern when used in commercial products or add regulatory requirements
from the presence of "excess" exogenous DNA.
Several methods have recently been introduced to remove marker genes in
plants, using site-specific recombination systems (e.g., lox/Cre
recombinase, Flp recombination target (FRT)/Flp recombinase, or Rs/R
recombinase) and by using an inducible promoter system (e.g. for b-estradiol)
for the recombinase gene. In these
recombination schemes, the marker gene is flanked by recombination sites, such
as lox, FRT, or Rs, which specifically interact with a recombinase
protein (e.g., Cre, Flp, or R, respectively).
This interaction promotes recombination between the sites and deletes the
marker DNA from the host genome. For
more information about these techniques see the references below.
-
David
W. Ow The right chemistry for
Marker Gene removal? (2001) Nature
Biotechnol. 19(2):
115 116.
-
Zuo,
J., Niu, Q.-W., Moller, S.G. & Chua, N.-H. Chemical-regulated,
site-specific DNA excision in transgenic plants. Nat.
Biotechnol. 19, 157-161 (2001).
-
Sugita,
K., Kasahara, T., Matsunaga, E. & Ebinuma. H.
A transformation vector for the production of marker-free transgenic plants
containing a single copy transgene at high frequency Plant J.
22, 461-469 (2000).
Small
Molecule Activator of Caspase-3.
Professor
Xiaodong Wang, and co-workers at the Department of Biochemistry, University of
Texas Southwestern Medical Center, Dallas, TX have identified a small molecule
activator of apoptosis, -(trichloromethyl)-4-pyridineethanol
(PETCM), using high-throughput screening in a panel of cancer cells in culture.
PETCM was found to be a selective activator of caspase-3.
Caspase-3 is an important member of the family of enzymes implicated in
the initial events of programmed cell death.
The identification of these types of active compounds, point the way
toward understanding the death initiator processes in tumor cells (two proteins
were implicated in the present study), and may lead to new types of
chemotherapies for intractable cancers. For
more information about this work, see the references below.
-
Distinctive
Roles of PHAP Proteins and Prothymosin-a in a Death Regulatory Pathway, X.
Jiang, H.E. Kim, H. Shu, Y. Zhao, H. Zhang, J. Kofron, J. Donnelly, D. Burns,
S.C. Ng, S. Rosenberg, X. Wang, Science 299 (2003)
223-226.
-
Apoptosis:
Life and Death Decisions D.W.
Nicholson and N.A. Thornberry, Science 299
(2003) 214-215.
Quantum
Dot Fluorescence Applications.
Quantum
dots (Qdots) are polymer-coated beads that contain nanometer scale microcrystals
of semiconductor material (cadmium selenide).
Arising from the solar energy research (photovoltaic cell conversion
studies) of the 1980s, they can be excited at a wide range of wavelengths
(300-500nm) and produce bright fluorescence emission, with the color dependent
upon the size of the contained nanocrystals.
In addition, they are much more photostable than typical fluorescent dyes.
Many quantum-dot bio-conjugates have been prepared and used in cell
labeling studies, and even intracellularly, with uptake by endocytosis.
For more information, see the references below.
-
Rosenthal,
S.J., Tomlinson, I., Adkins, E.M., Schroeter, S., Adams, S., Swafford, L.,
McBride, J., Wang, Y., DeFelice, I.J., Blakely, R.D., Targeting Cell
Surface Receptors with Ligand Conjugated Nanocrystals. J. Am. Chem.
Soc. 124(17):4586-4594 (2002).
-
kerman,
M.E., Chan, W.C., Laakkonen, P., Bhatia, S.N., Ruoslahti, E., Nanocrystal
Targeting In Vivo. Proc. Natl Acad. Sci. USA 99:12617-12621
(2002).
-
Watson,
A., Xingyong, W., Bruchez, M., Lighting Up Cells with Quantum Dots.
(2003) Biotechniques 34(2): 296-303.
Stems
Cells found Totipotent by lacZ Staining.
Dr.
Diana Clark and colleagues at the Medical Nobel Institute in Stockholm, Sweden
traced the differentiation of neural stem cells by lacZ transfection and
staining. They found these cells
could be induced to differentiate into most of the cells of the body.
This work is promising for use of stem cells to potentially re-populate
damaged tissue after stroke or spinal cord injury or aide in regenerating
tissues in multiple sclerosis, diabetes or neurodegenerative diseases.
For more information about these studies, see the references below.
Marker Gene sells several products for sensitive and specific staining of
lacZ-positive cells and tissues (including: M0250;
M0259; M0241;
M0255; and M0257).
-
Clarke,
D. L. Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlstrom H, Lendahl U,
Frisen J., Generalized potential of adult neural stem cells. Science
288, 1660-1663 (2000).
-
McKay,
R., Mammalian
deconstruction for stem cell reconstruction Nature Medicine (2000)
6( 7):747-748.
a-
Galactosidase Marker Gene for Yeast.
The
yeast two-hybrid screen is a genetic method of detecting protein-protein
interactions in vivo. Positive
clones are selected by their ability to activate the transcription of a reporter
gene, which also enables them to grow on nutritionally selective media.
Most two-hybrid methods use the E. coli lacZ gene as the reporter
gene. Usually the colonies growing
on the selection plates are assayed for the activation of the reporter gene lacZ
by a filter-lift assay. Marker Gene
currently produces several substrates that are useful for b-Gal detection in
yeast strains (M0250, FDG; M0203, Resorufin-Gal; M0252, TFMU-Gal, M0257, CUG).
Recently yeast strains producing the a-galactosidase marker gene have
been developed and used to assay GAL4-based two-hybrid interactions
directly on nutritional selection plates with the chromogenic substrate X-a-Gal.
Look for new products from Marker Gene in this area in the near future.
For more information about these techniques, see the references below.
-
S.
Aho, A. Arffman, T.Pummi and J. Uitto, A novel reporter gene MEL1 for
the yeast two-hybrid system. Anal. Biochem., 253, 270-272
(1997).
-
P.
Chevalier, D. Roy and and L. Savoie, X-a-gal-based medium for
simultaneous enumeration of bifidobacteria and lactic acid bacteria in
milk., J.Microbiol. Meth., 13, 75 (1991).
-
R.
Gossrau and Z. Lojda, Histochemical detection of a-D-galactosidase with
5-Br-4-Cl-3-indoxyl a-D-galactoside. Acta Histochem., 85,
213 (1989).
-
R.S.
Tubb and P.L. Liljestrom, A colony-colour method which differentiates
a-galactosidase positive strains of yeast. J. Inst. Brew. 92,
588, (1986).
Toward
a Marker Gene for Colorectal Tumors.
The
long-standing hope of finding specific reporter genes that are upregulated in
tumors has recently shown renewed promise in work published by Dr. Andrew
Feinberg and his group at Johns Hopkins University School of Medicine.
By examining the DNA methylation patterns of patients with genetic
predisposition to colorectal cancer or who have been diagnosed with the disease,
they found statistically higher levels of gene silencing in the gene IGF2 (insulin-like
growth factor 2) in these patients (5X or 21X higher respectively).
These assays were performed using a reverse transcription of mRNA
isolated by biopsy from colonoscopy tissue samples, using a PCR format with
specific primers. The levels of
methylation were analyzed by a bisulfite genomic sequencing method.
For more information about these techniques, please see the references
below.
-
H.
Cui, M. Cruz-Correa, F. M. Giardiello, D. F. Hutcheon, D. R. Kafonek, S.
Brandenburg, Y. Wu, X. He, N. R. Powe, and A. P. Feinberg, Loss
of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk
Science 299 (2003) 1753-55.
-
H.
Uejima, M. P. Lee, H. Cui, and A. P. Feinberg, Nature Genet. 25,
375-376 (2000).
-
Feinberg,
AP: Genomic imprinting and cancer. In The Metabolic and Molecular Bases
of Inherited Disease, 8th ed. Scriver CR, Beaudet AR, Sly W, Valle D (eds),
McGraw-Hill, New York, pp 525-537, 2001.
Hydrophobic
Stains for 2D-SDS-PAGE.
The
ability to stain proteins inside SDS-PAGE gels offers a significant advantage
over chemical labeling techniques or blotting / post-electrophoresis staining
and destaining methods. John Shultz
and Gregg Larson (Promega Corp., Madison, WI) recently introduced a number of
hydrophobic analogs of fluorescent dyes (fluorescein, Dansyl chloride,
carbocyanines, etc.) that can be used for direct and quantitative labeling of
proteins inside polyacrylamide gels. The
stains bind to the SDS hydrophobic protein coat and exhibit low background
fluorescence. For more information
about these stains and techniques, please see the references below.
-
Larson,
Gregg A.; Shultz, John W., Applications Of The Chromaphor Protein
Recovery System. BioTechniques, 15:316-323.
-
Shultz,
John W., Larson, Gregg A.., Protein Staining Compositions and Methods,
US Patent 5,705,649 (1998).
-
Kendrick,
N., Laser scanning quantification of 2-D gel spots using ChromaPhorTM
Green Stain, Promega Notes Magazine 37 (1992) 11.
AHAS
Reporter Gene in Plants.
Acetohydroxyacid
synthase (AHAS, EC 4.1.3.18) also known as acetolactate synthase, is an
herbicide-resistance selection marker used in plant cell studies.
It catalyzes the first step in branched-chain amino-acid (valine, leucine
and isoleucine) biosynthesis, and when a modified version is cloned into plants,
detoxifies the inhibition of the enzyme by sulfonylurea herbicides slufometuron
methyl and chlorosuluron (marketed by Du Pont as the active ingredients in Oust
and Glean, respectively) and the inidazolinone herbicides
2-(4-isopropyl-4-methyl-5-oxo-2-inidazolin-2-yl)-nicotinic acid and
2-(4-isopropyl-4-methyl-5-oxo-2-inidazolin-2-yl)-3-quinolinecarboxylic acid (marketed
by American Cyanamid as the active ingredients in Arsenal and Scepter,
respectively). The recombinant
plants carry a mutation (changing the serine (coded by AGT) at position 621 to
asparagine (AAT), which provides a relief of the inhibition by these herbicides.
An assay of this AHAS reporter has been developed, involving conversion
of the enzymatic product acetolactate to acetoin, followed by detection as a
complex with creatine and naphthol. For
more information about this selection marker gene in plants see the references
below.
-
Singh,
B.K., Stidham, M.A., Shaner, D.L., Assay of Acetohydroxyacid Synthase
Anal. Biochem. 171
(1988) 173-179.
-
Hill,
C.M., Pang, S.S., Duggleby, R.G., Purification of E.Coli acetohydroxyacid
synthase isoenzyme II and reconstitution of active enzyme from its
individual pure subunits. Biochem. J. 327 (1997) 891-898.
-
Schloss,
J.V., Van Dyk, D.E., Vasta,. J.F., Kutny, R.M., Purification and
Properties of Salmonella typhimurium Acetolactate Synthase Isozyme II from
E. Coli HB101/pDU9, Biochemistry 24 (1985) 4952-4959.
-
Zhu
T, Peterson DJ, Tagliani L, St. Clair G, Baszczynski CL, and Bowen B. 1999.
Targeted manipulation of maize genes in vivo using chimeric RNA/DNA
oligonucleotides. Proceedings of the National Academy of
Science 96:8768-8773.
-
Zhu
T, Mettenburg K, Peterson DJ, Tagliani L, and Baszczynski CL. 2000.
Engineering herbicide-resistant maize using chimeric RNA/DNA
oligonucleotides. Nature Biotechnology 18:555-558.
Bacterial
Detection using FDG
Fluorescein
di-b-D-Galactopyranoside (FDG,
M0250) is a
popular substrate for measuring cloned beta-Galactosidase activity in living
cells. It has also found utility in
staining and quantifying bacteria, as well as in isolating specific strains of
bacteria by fluorescence activated cell-sorting (FACS) analysis.
Interestingly, FDG was found to be about 70 times more sensitive in
bacterial assays than GFP.
For more information about FDG staining of bacteria, see the references
below:
-
b-Galactosidase
Activity in Single Differentiating Bacterial Cells." F. Russo-Marie,
Roederer, M. Sager, B., Herzenberg, L., Proc. Natl. Acad. Sci. USA 90:8194
(1993).
-
Nelis,
H.; Van Poucke, S. Enzymatic detection of coliforms and Escherichia coli
within 4 hours." Water, Air, and Soil Pollution (2000), 123(1-4):
43-52.
-
Dreier,
Jurg; Breitmaier, Eva B.; Gocke, Elmar; Apfel, Christian M.; Page, Malcolm
G. P. Direct influence of S9 liver homogenate on fluorescence signals:
impact on practical applications in a bacterial genotoxicity assay."
Mutation Research (2002), 513(1-2): 169-182.
-
Rowland
B ; Purkayastha A ; Monserrat C ; Casart Y ; Takiff H ;
McDonough KA (1999) Fluorescence-based detection of lacZ reporter gene
expression in intact and viable bacteria including Mycobacterium species
FEMS Microbiol. Lett. 179(2): 317-25
|
Whole
body Luciferase detection
in vivo.
Dr.
Christopher Contags group at Stanford Medical School, along with
collaborators at Xenogen Corp. have recently demonstrated the ability
to measure light emission from transfected firefly luciferase activity
inside living tissues and in vivo by injecting live animals
with D-luciferin (M0237).
The ability to measure tumor growth and tumor burden in vivo
as well as the possibility to streamline development of many types of
therapies, including DNA-based gene therapies and gene vaccines, are
exciting. For more
information about whole body luciferase gene analysis, see the
references below:
-
Christopher
H. Contag, Stanley D. Spilman, Pamela R. Contag, Masafumi Oshiro,
Brian Eames, Phyllis Dennery, David K. Stevenson, David A. Benaron
Visualizing Gene Expression in Living Mammals Using a
Bioluminescent Reporter Photochemistry and Photobiology (1997) 66(4):
523-531.
-
Pamela
R. Contag, I. Nick Olomu, David K. Stevenson and Christopher H.
Contag, Bioluminescent Indicators in Living Mammals
Nature Medicine, New Technology Section (1998) 4(2):245-247.
|
|
Protein
traffic using caged-GFP.
The
movement of proteins inside the cell is an important area of study for
understanding their function and interactions with intracellular
organelles. Dr. Jennifer
Lipppincott-Schwartzs lab at NIHs Cell Biology and Metabolism
Branch (NICHD) is studying the trafficking kinetics of proteins
traversing the secretory and endocytic pathways and how they are
affected by different pharmacological and physiological conditions
using some newly developed caged-GFP protein tools.
A new GFP, called PA-GFP (for photo-activatable green
fluorescent protein) has been modified at position 203 with a
histidine substitution. This
PA-GFP can be activated by a short pulse of light at 413nm and used to
follow the distribution of PA-GFP fusion proteins inside the cell in a
temporal fashion. For
more information about these cell monitoring techniques, see the
references below:
-
Hirschberg,
K., Miller, C.M, Presley, J.F., Ellenberg, J., Zaal, K., Cole, N.B.,
Siggia, E., Phair, and Lippincott-Schwartz, J. (1998) Kinetic and
morphological analysis of secretory protein traffic in living
cells. J. Cell Biol. 143: 1485-1503.
-
Patterson,
G.H., Lippincott-Schwartz, J., (2002) A Photoactivatable GFP for
Selective Photolabeling of Proteins and Cells. Science 297(5588):
1873-1876.
|
|
Human
Antibody Production in Plants.
Transgenic
plants have been engineered by researchers from the Scripps Research
Institute and Epicyte
Pharmaceuticals (San Diego, CA) to produce recombinant human
monoclonal antibodies. These
plant-based systems can provide significant cost advantages
over traditional mammalian cell culture systems.
In addition, the unwanted effects of immune-sensitive
glycosylation patterns are reduced from expression in plant systems.
Among the antibodies currently under production are those for
HSV, HIV, pneumonia (respiratory syncytial virus) and intestinal
infection (clostridium difficile).
For more information about these plant expression systems, see
the references below:
-
Zeitlin
L, Olmsted S, et al. (1998). "A humanized monoclonal antibody
produced in transgenic plants for immunoprotection of the vagina
against genital herpes" Nature Biotechnology16:1361-1364:
-
Ma
JK-C, Lehner T, Stabila P, Fux C, Hiatt AC (1994). "Assembly
of monoclonal antibodies with IgG1 and IgA heavy chain domains in
transgenic tobacco plants" Euro. Jr. Immunol. 24:
131-138.
-
Ma,
JK-C, Hiatt AC, Hein MB, Vine ND, Wang F, Stabila P, van
Dolleweerd C, Mostov K, Lehner T (1995). "Generation and
assembly of secretory antibodies in plants" Science 268:
716-719.
|
|
Lipase
Activity measured in Live Cells.
Triacylglycerides
are metabolized inside living cells by lipases [EC 3.1.1.3].
In normal serum the concentration of lipase is low. In acute
pancreatitis and in pancreatic carcinoma a rise in serum lipase
activity occurs, with a mean increase being about 50 times that of
normal values. A rise in the serum lipase content is also found in
acute and chronic renal diseases.
Sensitive measurement of lipase activity in live cells can be
accomplished using the fluorescent substrate 1,2-Dioleoyl-3-(pyren-1-yl)decanoyl-rac
Glycerol (M0258).
Upon enzymatic cleavage, the fluorescent fatty acid, pyrenedecanoic
acid (M0274)
is released, which accumulates in cellular membranes.
Upon eximer formation, the fluorescence of this product shifts
to longer wavelength, and can be distinguished from that of the
substrate, because it forms eximers inside the membrane (EM: 470nm @
EX: 390nm). This assay is
quantitative and can be used with mammalian or bacterial cell lines.
For more information about this assay see the references below:
NOTE: Marker Gene also sells a convenient Fluorescent
Lipase Assay Kit (M0612) with all of the reagents and a
detailed protocol for measuring lipase activity in living cells.
-
Dousset,
N., Negre, A., Salvayre, R., Rogalle, P., Dang, Q.Q., Douste-Blazy,
L. (1988). Use of a fluorescent radiolabeled triacylglycerol as a
substrate for lipoprotein lipase and hepatic triglyceride lipase.
Lipids 23: 605-608.
-
Main,
L.A., Okumura-Noji, K., Ohnishi, T., Yokoyama, S., (1998)
Cholesteryl ester transfer protein reaction between plasma
lipoproteins. J. Biochem. (Tokyo) 124: 237-243.
|
Jet-Lag
and Circadian Rhythms in Plants.
The
effects of daylight length and time-changes, and the physiological events that
occur in eukaryotic cells in response to these events, have long intrigued
scientists. Some of these processes
are beginning to be understood in plants and animals by cloning marker genes (for
example firefly luciferase, luc) into cells under control of specific
circadian promoter elements. By
adding the reagent D-luciferin
(M0237) to these
cloned tissues, Steven Kays lab at the Scripps Research Institute in San
Diego (see: http://www.scripps.edu/cb/kay/)
has identified several new genes that light up, i.e. are responsible for
the physiological changes in plants and animals, when daylight and night-time
cycled gene expression occurs. For
more information, see the references below:
-
Covington,
M.F., Panda, S., Liu, X.L., Strayer, C.A., Kay, S.A., Wagner, D.R. (2001)
ELF3 modulates resetting of the circadian clock in Arabidopsis. The Plant
Cell 13, 1305-1316.
-
Millar
A.J. and Kay S.A. (1996). Integration of circadian and phototransduction
pathways in the network controlling CAB gene transcription in
Arabidopsis. Proc. Natl. Acad. Sci. USA, 93, 15491-15496.
-
Millar
A.J., Straume M., Chory J., Chua N.-H. and Kay S.A. (1995) The regulation of
circadian period by phototransduction pathways in Arabidopsis. Science,
267, 1163-1166.
|
FDG
Staining of live Zebrafish Embryos
Over
the last several years, the zebrafish has emerged as an attractive
model for vertebrate developmental biology, largely because of the
ease of genetic analysis and the transparent nature of the embryo.
However, despite many advantages, zebrafish researchers still
require certain experimental tools, including viable embryonic markers
for genetic and cell lineage studies.
Staining with the fluorescent b-galactosidase substrate FDG
(M0250)
is a popular method of detecting transgenic activity in these embryos
when using the lacZ reporter gene, but may require dechorionation of
the embryos prior to staining.
See
the references below for more information about these techniques.
-
Rossant,
J., Hopkins, N. (1992) Of fin and fur: mutational analysis of
vertebrate embryonic development.
-
Genes
Devel. 6:113.Lin S, Yang S, Hopkins N. lacZ
expression in germline transgenic zebrafish can be detected in
living embryos. Dev. Biol. (1994) 161(1):77-83
|
Oxidative
Burst in Neutrophils with DHR123
The
reduced or missing oxidative burst activity in leukocytes is an
indication of hereditary diseases like chronic granulomatous disease (CGD).
Treatment of cells (e.g. heparinized whole blood) with the
reduced dye DHR123, (dihydrorhodamine
123, M0545)
is a sensitive assay for oxidative activity in such cells, with allied
induction using either the chemotactic peptide N-formyl-Met-Leu-Phe (fMLP),
the protein kinase C ligand phorbol 12-myristate-13-acetate (PMA) or
bacterial challenge. DHR123
is practically non-fluorescent until oxidized intracellularly to the
bright red fluorescent rhodamine 123 product.
For more information see the references listed below or visit
our Website:
-
Rothe
G, Oser A & G. Valet. (1988) Dihydrorhodamin 123: a new flow
cytometric indicator for respiratory burst activity in neutrophil
granulocytes. Naturwissenschaften 75: 354 - 355.
-
Dobmeyer,
T.S., Raffel, B. Dobmeyer, J.M., Findhammer, S., Klein, S.A.,
Kabelitz, D. Hoelzer, D., Helm, E.B. & Rossol.(1995) Decreased
function of monocytes and granulocytes during HIV-1 infection
correlates with CD4 cell counts. Eur. J. Med. Res. 1: 9-15.
-
Gessler,
P., Nebe, T. Birle, A., Haas, N. & W. Kachel. (1996)
Neutrophil respiratory burst in term and preterm neonates without
signs of infection and in those with increased levels of
C-Reactive Protein. Pediatr. Res. 39: 843-848.
-
Elbim,
C., Chollet-Martin, S., Bailly, S., Hakim, J. & M.A.
Gougerot-Pocidalo. (1993) Priming of polymorphonuclear neutrophils
by tumor necrosis factor in whole blood: Identification of two
polymorphonuclear neutrophil subpopulations in response to
formyl-peptides. Blood 82: 663-640.
|
|
Adoptive
Immunotherapy for Melanomas
Steven
Rosenbergs laboratory at the
National Cancer Institute recently reported results of a new study
were reactive killer T-cells were removed from patients tumor
regions, and grown in culture to high density.
When re-infused into these same patients, their ability to
mount an immune response to the tumors was highly improved.
The key factors of cell viability (and proliferation) during
culturing and after re-infusion were addressed using a regimen where
the patients own immune system was depleted before transfer (prior
lymphodepletion using a combination of drugs).
These techniques present a potential promising new weapon for
the treatment of cancer using the bodys own immune system.
-
Dudley
et al. (2002) Cancer
Regression and Autoimmunity in Patients After Clonal Repopulation
with Antitumor Lymphocytes. Science
298 (5594): 850-854.
-
Winter,
H., Fox, B.A., Adoptive Cellular Immunotherapy of Cancer. Current
Opinion in Molecular Therapeutics. 1 (1):89-97,1999.
|
Black
Spot Disease in Citrus Fruits
Black
Spot is a fungal disease caused by Guignardia citricarpa. It
causes black lesions on citrus fruits like oranges and grapefruits,
and is becoming a threat to the US agriculture industry.
The disease has not been reported in U.S. citrus producing
states, but has been found in parts of Australia, South Africa and
Argentina and is becoming a serious problem in Brazil.
Importation or export of fruits from the US are in jeopardy
since the European Union (EU) and South Africa in 2000 now threaten to
slow citrus exports because of zealous application of protective
standards. Recently
several assays including a definitive PCR-based assay have been
developed, which may alleviate these quarantine issues.
For more information on the disease and these assays, see the
references below:
-
Baayen,
R.P. , (2002) Nopathogenic isolates of the citrus black spot
fungus, Guignardia citricarpa, identified as a cosmopolitan
endophyte of woody plants, G. mangiferae (Phyllosticta
capitalensis), Phytopathology 92 (5): 464-477.
|
| MGT-M0114 |
2',7'-bis(Carboxyethyl)-5(6)
carboxyfluorescein [BCECF] |
| MGT-M0637 |
2-Chloro-4-nitrophenyl-b-D-cellobioside |
| MGT-M0553 |
2-Chloro-4-nitrophenyl-b-D-lactoside |
| MGT-M0241 |
4-Methylumbelliferyl b-D-galactopyranoside [MUGal] |
| MGT-M0240 |
4-Methylumbelliferyl b-D-glucuronide [MUGlcU] |
| MGT-M0554 |
4-Methylumbelliferyl-b-D-lactoside |
| MGT-M0252 |
4-Trifluoromethylumbelliferyl-b-D
galactopyranoside [TFMU-Gal] |
| MGT-M0122 |
5(6)-Carboxyfluorescein |
| MGT-M0276 |
b-Galactosidase Sample Kit |
| MGT-M0272 |
Carbohydrate Analysis/Detection Kit |
| MGT-M0011 |
Carboxyfluorescein di-O-acetate [CFDA] |
| MGT-M0013 |
Carboxyfluorescein di-O-acetate, NHS ester |
| MGT-M0257 |
Carboxyumbelliferyl b-D-galactopyranoside [CUGal] |
| MGT-M0256 |
Carboxyumbelliferyl b-D-glucuronide [CUGlcU] |
| MGT-M0520 |
Cyclic adipoyl-(6-amino)hexanoyl-DEVD-rhodamine
110 . TEA salt |
| MGT-M0147 |
Cycloheximide 2-O-b-D-galactopyranoside |
| MGT-M0149 |
Dexamethasone 21-O-b-D-galactopyranoside |
| MGT-M0545 |
Dihydrorhodamine 123 [DHR123] |
| MGT-M0583 |
Etoposide 4-O-b-D-galactopyranoside |
| MGT-M0255 |
FACS lacZ b-Galactosidase Detection Kit |
| MGT-M0250 |
Fluorescein di-b-D-galactopyranside [FDG] |
| MGT-M0308 |
Fluorescein di-b-D-N-acetylgalactoside |
| MGT-M0060 |
Fluorescein di-O-acetate [FDA] |
| MGT-M0064 |
Fluorescein mono-b-D-galactoside [FMGal] |
| MGT-M0065 |
Fluorescein mono-b-D-glucoside [FMGlc] |
| MGT-M0204 |
Fluorescein, high purity standard |
| MGT-M0612 |
Fluorescent Lipase Assay Kit |
| MGT-M0259 |
In vivo lacZ b-Galactosidase Intracellular
Detection Kit |
| MGT-M0626 |
Luciferase Assay Kit |
| MGT-M0237 |
Luciferin |
| MGT-M0271 |
Membrane Fluidity Kit |
| MGT-M0260 |
Phenethylthio-b-glucoside [PETG] |
| MGT-M0261 |
Phenethylthio-b-glucuronide [PETGU] |
| MGT-M0215 |
Phorbol
12-O-octanoyl-13-O-acetyl-6-O-b-D-galactopyranoside |
| MGT-M0203 |
Resorufin b-D-galactopyranoside [Res-Gal] |
| MGT-M0202 |
Resorufin, high purity standard |
| MGT-M0041 |
Trifluoromethylumbelliferone [TFMU] |
| | |